Aurora Cannabis (ACB) Cash & Current Investments (2018 - 2026)
Aurora Cannabis (ACB) posted quarterly Cash & Current Investments of $85.2 million for Q1 2026, down 11.31% year-over-year from $96.1 million in Q1 2025, and up 9.62% quarter-over-quarter from $77.8 million in Q4 2025.
Aurora Cannabis (ACB) Cash & Current Investments (2018 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Cash & Current Investments for 9 consecutive years, with $85.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Current Investments fell 11.31% year-over-year to $85.2 million; the TTM figure through Mar 2026 stood at $85.2 million (down 11.31% YoY), while the FY2026 annual figure was $85.2 million, down 14.08% from the prior year.
- Cash & Current Investments improved to $85.2 million in Q1 2026 per ACB's latest filing, from $77.8 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $364.0 million in Q2 2022 and bottomed at $77.8 million in Q4 2025.
- Historically, Cash & Current Investments has averaged $172.2 million across 5 years, with a median of $146.1 million in 2024.
- Annual changes were most pronounced in 2023 — Cash & Current Investments tumbled 54.29% — and 2024, when it rose 0.8%.
- Aurora Cannabis' Cash & Current Investments stood at $207.4 million in 2022, then declined by 27.41% to $150.6 million in 2023, then decreased by 2.97% to $146.1 million in 2024, then plunged by 46.77% to $77.8 million in 2025, then gained by 9.62% to $85.2 million in 2026.
- Business Quant data shows ACB's Cash & Current Investments at $85.2 million in Q1 2026, $77.8 million in Q4 2025, and $103.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | 963.33 Mn |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | 5.80 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 2.66 Bn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 389.80 Mn |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | 164.00 Mn |
| 10 | Aurora Cannabis | 233.15 Mn | 160.83 Mn | 25.75 Mn | 72.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 85.25 Mn |
| Dec 31, 2025 | 77.77 Mn |
| Sep 30, 2025 | 103.14 Mn |
| Jun 30, 2025 | 134.26 Mn |
| Mar 31, 2025 | 96.12 Mn |
| Dec 31, 2024 | 146.10 Mn |
| Sep 30, 2024 | 127.73 Mn |
| Jun 30, 2024 | 167.73 Mn |
| Mar 31, 2024 | 101.56 Mn |
| Dec 31, 2023 | 150.58 Mn |
| Sep 30, 2023 | 143.83 Mn |
| Jun 30, 2023 | 166.39 Mn |
| Mar 31, 2023 | 189.06 Mn |
| Dec 31, 2022 | 207.45 Mn |
| Sep 30, 2022 | 302.78 Mn |
| Jun 30, 2022 | 364.00 Mn |
| Mar 31, 2022 | 362.87 Mn |
| Dec 31, 2021 | 292.85 Mn |
| Sep 30, 2021 | 329.89 Mn |
| Jun 30, 2021 | 391.18 Mn |